HomePosts Tagged "CRISPR"

This platform functions efficiently at temperatures as low as 4°C.

The CRISPR gene-editing technology has scaled to a new height in India. Indian scientists have demonstrated for the first time that the associated Cas9 enzyme, which acts as molecular scissors to cut DNA at a location specified by a guide RNA, can bind to and cut the target DNA at very low temperatures.

This work has shown the highly efficient functioning of this platform at temperatures as low as 4°C. making it possible to edit genes in temperature sensitive organisms, plants, or crop varieties.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) are short DNA sequences found in the genome of prokaryotic organisms such as bacteria, which are reminders of previous bacteriophage (viruses) attacks that the bacteria successfully defended against. Cas9 enzyme (part of bacteria’s defence mechanism) uses these flags to precisely target and cut any foreign DNA, thus protecting the bacteria from future attacks by similar bacteriophages. The unprecedented precision of targeting the DNA sequences and then efficiently cutting them is the basis for CRISPR-Cas9 technology, which has been recently demonstrated in editing genes in cells and organisms.

CRISPR-Cas9 technology has been successfully used for many purposes, including basic studies of gene function, agriculture, and medicine to increase our knowledge of disease processes and their potential future therapies. So far, most binding trials were typically performed at 37 °C.

As a further step to advance this platform into the forefront of biomedical and analytical biotechnology, scientists of Raman Research Institute (RRI), an autonomous institute of the Department of Science and Technology (DST), have explored temperature-dependent binding and release of cleaved products by the Cas9 enzyme. Serene Rose David, Sumanth Kumar Maheshwaram, Divya Shet & Mahesh B. Lakshminarayana, under the guidance of Dr Gautam V Soni, have demonstrated that the Cas9 enzymes strongly bind to the target at very low temperatures and remains bound to the cleaved DNA products even after the enzyme has done its job.

Subsequently, the bound products were released in a controlled fashion using high temperature or chemical denaturant (that make proteins and DNA lose their 3-dimensional structure and become non-functional). The research published in the Scientific Reports journal of the Nature Portfolio expands possible application of the Cas9-based genetic toolbox to a previously unexplored temperature range that would be compatible with long-term storage of biological samples.

This platform functions efficiently at temperatures as

Origin is currently in trials to develop new corn varieties that have been genetically engineered to have balanced amino acid content.

Headuartered in China, Origin Agritech Limited, an agriculture technology company has recently announced that it is developing nutritionally enhanced corn using CRISPR technology.

Origin is currently in trials to develop new corn varieties that have been genetically engineered to have balanced amino acid content. If these trials are successfully completed, it will validate Origin’s next generation methodology in applying CRISPR technology to develop new corn varieties.

CRISPR gene editing does not introduce foreign DNA into the corn and as such more closely mimics gene mutations that frequently occur in nature. Additionally, the time and cost of developing genetically engineered corn using CRISPR is a fraction versus what it would be using traditional GMO technology. 

Dr Gengchen Han, Origin Agritech’s Chairman, said, “Our nutrition balanced corn trait would not only significantly reduce the need for costly additives in animal feed, it will also pave the way for many more applications of CRISPR technology.”

Origin is currently in trials to develop